Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive monotherapy with nitrendipine in general practice.

H Braun1, F Weber

  • 1Bayer (Schweiz) AG, Zurich, Switzerland.

Journal of Cardiovascular Pharmacology
|January 1, 1991
PubMed
Summary

Nitrendipine, a calcium channel blocker, effectively treated mild to moderate essential hypertension in a 6-month study. This antihypertensive medication demonstrated good tolerability and is suitable for initial therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lenvatinib as salvage therapy in advanced and progressive GI-NET.

Endocrine-related cancer·2025
Same author

Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection.

European journal of pediatrics·2024
Same author

Usability and preliminary effectiveness of an app-based physical activity and education program for people with hip or knee osteoarthritis - a pilot randomized controlled trial.

Arthritis research & therapy·2024
Same author

Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz™).

Pathology, research and practice·2023
Same author

[Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Chirurgie (Heidelberg, Germany)·2022
Same author

[Reddish painless rapidly growing tumor of the upper eyelid with a smooth surface: Merkel cell carcinoma].

Die Ophthalmologie·2022

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Research

Background:

  • Essential hypertension is a widespread condition requiring effective and well-tolerated treatments.
  • Calcium channel blockers are a key class of antihypertensive medications.
  • Nitrendipine is a dihydropyridine calcium antagonist used for blood pressure management.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of nitrendipine as a monotherapy for mild to moderate essential hypertension.
  • To determine the optimal dosage and treatment outcomes in a real-world clinical setting.

Main Methods:

  • An open-label, 6-month trial involving 495 patients with mild to moderate essential hypertension.
  • Patients previously on antihypertensive therapy had it withdrawn before initiating nitrendipine (20 mg once daily).

Related Experiment Videos

  • Dosage adjustments (10 mg, 20 mg, or 20 mg twice daily) were made based on patient response.

    • Main Results:

    • Nitrendipine monotherapy achieved goal blood pressure in 75% of 411 evaluable patients.
    • An additional 6% achieved diastolic blood pressure between 90-95 mm Hg.
    • Side effects, primarily headaches, flushing, and ankle edema, led to discontinuation in some patients, but overall tolerability was good.
    • Older patients (>60 years) showed a more significant reduction in systolic blood pressure.

    Conclusions:

    • Nitrendipine is an effective and well-tolerated option for first-line monotherapy in patients with mild to moderate essential hypertension.
    • The medication demonstrated consistent efficacy across different age groups, with enhanced effects in older individuals.
    • Nitrendipine monotherapy offers a viable treatment strategy for managing essential hypertension.